top of page

How The IRA Could Delay Pharmaceutical Launches, Reduce Indications, And Chill Evidence Generation

Clinical development programs for new drugs include an array of research conducted both before and after a drug’s initial approval by the Food and Drug Administration (FDA). Post-approval clinical trials may be conducted in new patient populations to support additional indications and to demonstrate long-term safety and efficacy, including impacts on overall survival or major health events.


Comentarios


bottom of page